Oncology

Chronic Myeloid Leukemia ‘To Become A Very Indolent Disease’: Pregnancy Possible, Transplants Avoided—Mission Accomplished?

April 21, 2009
Hagop Kantarjian MD

Hagop Kantarjian MD

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Hagop Kantarjian MD from the MD Anderson Cancer Center in Houston about his latest findings on treating CML in patients who have the T315I mutation. He also discusses the feasibility of patients becoming pregnant while having tyrosine kinase inhibitor (TKI) treatment (among those who have achieved stability for at least two years); and talks about the decreased need for allogeneic transplant.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Audio Journal of Hematologic Malignancy Special Edition 2005

    • Reporting from: - Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego - Lymphoma: The Next Questions, April

  • ASCO Audio Journal of Oncology – September 1st, 2006

    • Mark Socinski

  • Audio Journal of Oncology 14.2, March 2006

    • Reporting from: American Society of Hematology Meeting, Atlanta, 10-13 December 2005 Scientific Editors: George Canellos, Dana-Farber Cancer Institute, Boston Gordon McVie, European Institute of

    Post a comment